| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $3,479,094 ) |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Precision Medicine for the Peripheral Nervous System Disorder Familiar Dysautonomia | 000 | 4 | NIH | 11/24/2023 | $339,750 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI172787 | Investigating a signaling molecule that cooperates with quorum sensing to induce biofilm formation in C. neoformans | 000 | 2 | NIH | 10/26/2023 | $169,875 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG076625 | Implications of Metabolic Dysfunction during Thiamine Insufficiency | 000 | 2 | NIH | 11/7/2023 | $331,600 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171944 | Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection | 000 | 2 | NIH | 12/5/2023 | $165,800 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI170106 | Develop and Assess mRNA Lipid Nanoparticle Vaccines Against Cryptococcosis | 000 | 2 | NIH | 12/6/2023 | $195,906 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R03AI176262 | Investigation of uncharacterized fungal-specific genes in dormant conidia | 000 | 2 | NIH | 12/7/2023 | $67,950 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI172807 | Evaluation of Streptamine Analogs to Overcome Resistance to Apramycin | 000 | 2 | NIH | 10/23/2023 | $184,530 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES034196 | Role of Prokineticin 2 in Metal Neurotoxicity | 000 | 2 | NIH | 10/18/2023 | $339,750 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK124366 | Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020 | 000 | 4 | NIH | 11/21/2023 | $448,029 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173144 | Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus | 000 | 2 | NIH | 11/1/2023 | $411,969 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148433 | O-glycosylation of cysteine-rich modules | 000 | 2 | NIH | 11/14/2023 | $394,110 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173084 | Epitope and mechanistic correlates of broadly protective human antibodies for pneumococcal infection | 000 | 2 | NIH | 11/1/2023 | $653,539 |
| | 2024 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K99GM144742 | Exploration of cis-regulatory diversity underlying phenotypic innovation | 000 | 2 | NIH | 11/7/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI166563 | Mechanistic Studies of Viral Host Cell Recognition and Entry and their Implication for Protein Design of Molecular Delivery Devices | 001 | 2 | NIH | 11/7/2023 | -$1 |
| | 2024 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | H79SP082105 | Project NaviGAte: Connecting Georgia to Substance Use and HIV Prevention | 000 | 4 | SAMHSA | 10/26/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | H79SM084376 | Connecting Extension with Communities to Reduce Mental Health Stigma | 000 | 1 | SAMHSA | 10/13/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | H79SM084376 | Connecting Extension with Communities to Reduce Mental Health Stigma | 000 | 1 | SAMHSA | 10/13/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U01AG074960 | Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias | 000 | 2 | NIH | 11/2/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM136827 | Regulation of the Translational Response to Cellular Stress | 001 | 5 | NIH | 10/27/2023 | $261,947 |
| | 2024 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI140245 | Design of Antivirals and Immunogens Targeting Paramyxoviruses | 000 | 6 | NIH | 11/27/2023 | $10,021 |
| | 2024 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01DA049292 | Neuroimaging approaches to improve prediction of smoking initiation and nicotine use escalation among young adult electronic nicotine delivery systems users | 000 | 3 | NIH | 11/7/2023 | -$49,610 |
| | 2024 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI166563 | Mechanistic Studies of Viral Host Cell Recognition and Entry and their Implication for Protein Design of Molecular Delivery Devices | 000 | 1 | NIH | 11/7/2023 | -$115,196 |
| | 2024 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI154931 | Elements of the Ca2+ signal transduction pathway of Toxoplasma gondii | 000 | 2 | NIH | 11/1/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31DA053828 | Dimensional Adversity and Neural Vulnerabilities for Substance Use Among Rural and Non-Rural Adolescents | 000 | 1 | NIH | 10/31/2023 | -$331 |
| | 2024 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R36MH127838 | Revision and Validation of the Multidimensional Assessment of Parenting Scale (MAPS) in a Racially and Ethnically Diverse National Sample | 000 | 2 | NIH | 11/8/2023 | -$178 |
| | 2024 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM128620 | Engineering Dynamic Control of Natural Product Biosynthesis in Bacteria | 000 | 5 | NIH | 10/27/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AR075317 | Tpl2 regulation of pDC function and SLE pathogenesis | 000 | 2 | NIH | 11/8/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U2CES030167 | Portal for Open Computational Metabolomics Tools - Yr 4 U2C Supplement | 000 | 4 | NIH | 11/7/2023 | -$40,751 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U01GM125267 | Glycan Structure Archive (GSA) prototype in support of GlyGen's data integration - Yr 5 Admin Supp | 001 | 5 | NIH | 11/7/2023 | -$8,967 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI152495 | Signaling by inositol pyrophosphates in Toxoplasma gondii (RESUBMISSION) | 000 | 2 | NIH | 11/7/2023 | -$1,536 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R03AA027009 | The Effect of Vicarious Exposure to Social Defeat on Alcohol Intake | 000 | 2 | NIH | 11/8/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U01GM125267 | Glycan Structure Archive (GSA) prototype in support of GlyGen's data integration - Yr 5 Admin Supp | 000 | 5 | NIH | 11/7/2023 | -$115,677 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U01CA239106 | A data analytics framework for mining the dark kinome | 000 | 2 | NIH | 11/8/2023 | -$1 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD090156 | Characterization of the role of POFUT2-mediated O-fucosylation in folding Thrombospondin Type 1 Repeats and Development | 000 | 5 | NIH | 11/7/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U2CES030167 | Portal for Open Computational Metabolomics Tools - Yr 4 U2C Supplement | 001 | 4 | NIH | 11/7/2023 | -$9,283 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T32GM007103 | T32 Predoctoral training grant in genetics | 001 | 46 | NIH | 11/7/2023 | -$20,402 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T32GM007103 | T32 Predoctoral training grant in genetics | 000 | 46 | NIH | 11/7/2023 | -$56,976 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | S10OD028613 | Flow cytometer Cell Sorter for Biosafety Level-3 Facility | 000 | 1 | NIH | 11/8/2023 | -$357 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R56AI158743 | Synthetic multi-component influenza vaccines to elicit broad immunity | 000 | 1 | NIH | 11/7/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA204846 | Overcoming Cancer Resistance Mediated by the Human MDR1 Transporter | 000 | 5 | NIH | 11/8/2023 | -$52,368 |
| | 2024 | 2021 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI128924 | Pathogenesis of Jeilongvirus | 000 | 5 | NIH | 11/7/2023 | $0 |
| | 2024 | 2020 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21CA241570 | Testing Financial Incentive Interventions in Dyadic-Smoker Couples | 000 | 1 | NIH | 11/8/2023 | -$6,496 |
| | 2024 | 2020 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI125738 | Multiplex treatment outcomes test for Chagas disease | 000 | 5 | NIH | 11/7/2023 | -$17,553 |
| | 2024 | 2020 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI146448 | Flu-IGIP: Live attenuated influenza virus vaccines with improved stimulation of IgA responses | 000 | 2 | NIH | 11/7/2023 | $0 |
| | 2024 | 2020 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES026892 | Protein Aggregation and Inflammasome Signaling in Manganese Neurotoxicity. | 000 | 6 | NIH | 11/7/2023 | -$1 |
| | 2024 | 2020 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21NS119167 | NSC Function in a Motor Cortex TBI | 000 | 1 | NIH | 11/8/2023 | $0 |
| | 2024 | 2020 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21NS118224 | Microglial RGS10 as a therapeutic target for Lewy body diseases | 001 | 1 | NIH | 11/7/2023 | $0 |
| | 2024 | 2020 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21NS118224 | Microglial RGS10 as a therapeutic target for Lewy body diseases | 000 | 1 | NIH | 10/30/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $72,117,402 ) (Continued on the next page) |
|
